Cell Culture Market Analysis and Demand Estimated By Global Players
Posted by Rajkumar on March 5th, 2019
Cell culture is fast emerging as an important tool for diagnosing and clinically treating various disease such as cancer and Alzheimer’s. Companies are focusing on diversifying their cell depository and enhancing their expertise by laying major emphasis on recruitment of highly trained professionals in order to gain a competitive edge in the market. The European Collection of Authenticated Cell Cultures (ECACC) is serving the patent depository for Europe for carrying out research by acting as international depository authority. According to VF Bioscience SAS, cell culture technique is also gaining popularity in the field of food and beverages, a trend that is estimated to gain significant traction in 2017. Furthermore, cell culture are also gaining preference as an important ingredient in production of high quality plant actives.
Download PDF Brochure Of This Research Report @ https://bit.ly/2VyoeT5
Cell culture process can include various complications such as obtaining fully traceable botanical extracts and raw material supply. Furthermore, increasing focus on ensuring regulatory compliance related to environmental sustainability can hamper efficacy of the product. To overcome these complications in 2017, in place of using wild or field-grown plants, researchers at ABResearch srl utilized the callus cultures and cell suspension cultures for better results. According to News Medical Life-sciences, in 2017, researchers are inclined towards developing culture model that can be used in early treatment of age-related macular degeneration (AMD). AMD is the third major cause for total vision loss and also more prevalent in elderly people.
The global cell culture market was valued at US$ 12,251.3 million in 2015 and is expected to witness a robust CAGR of 7.1% during the forecast period (2016 – 2024).
Increasing research on personalized therapies and stem cells is driving growth of the market for cell culture. Also, growing organ transplantation and biobanking of cells tissues and organs is driving growth of the market for cell culture instruments and consumables. According to the Global Observatory on Donation and Transplantation (GODT), around 119,873 organs were transplanted worldwide in 2014 (1.81% increase over 2013). The demand-supply gap of organ transplantation is a major problem faced globally. In the U.S. alone, nearly 118,652 patients are waiting for organ transplant (U.S. Department of Health & Human Service, 2017). Using cell culture technique to differentiate cells of liver, heart and nervous system would aid in the treatment of millions of such patients globally. Further, advent of 3D cell culture technique has enabled researchers to understand the body physiology and biological systems much better. Moreover, the spheroid formation and scaffold-based techniques are driving demand for 3D cell culture products.
This report segments the global cell culture market on the basis of products, applications, end user, and geography. On the basis of product type, the market is segmented into consumables and instruments. The consumables market is categorized into media, sera, and reagents. The instruments market is categorized into culture systems, incubators, pipette, roller bottles, cryostorage equipment and biosafety cabinets. The end users segment comprises academic and research institutes and commercial pharma and biotech product manufacturers. For comprehensive understanding of market dynamics, the global cell culture market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Request For Customization of Research Report @ https://bit.ly/2SC4aO1
Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., GE Healthcare, Corning, Inc., Sigma - Aldrich Corporation, VWR International, LLC, Merck KGAA, Becton, Dickinson and Company, Eppendorf AG, Sartorius AG and Lonza Group AG
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Like it? Share it!
About the AuthorRajkumar
Joined: February 13th, 2019
Articles Posted: 705
More by this author